FeesSafety
Pluang+

Consumer spending risks a sharp drop as wages lag behind rising prices amid inflation and weak job growth.

Market News
03 Nov 2026, 15:00 WIB
Market Watch
View Source
Bearish
Consumer spending risks a sharp drop as wages lag behind rising prices amid inflation and weak job growth.

Consumer spending, which drives nearly 70% of U.S. GDP, shows signs of strain as wages have not kept pace with rising prices since the COVID-19 recession. Inflation, worsened by the Iran war, has caused prices to rise faster than wages for six consecutive months. Despite low unemployment, weak job growth limits wage increases, raising concerns that consumers may soon struggle with debt and reduced spending. This potential 'spend-pocalypse' could significantly impact the U.S. economy if consumers cut back sharply on purchases.

The story on cash-strapped consumers nearing a 'spend-pocalypse' is set against a backdrop of mixed performance in the Consumer Cyclical sector. Of 134 priced US stocks in this sector on Pluang, 40 rose and 85 fell. Notable movers include Allbirds Inc (BIRD) up 6.79%, Carparts.Com Inc (PRTS) down 6.71%, and Global E Online Ltd (GLBE) down 4.79%, as of Nov 03, 2026 19:51 WIB.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
21 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App